Immatics
targeting so | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
33 of 75
Related slides by other companies
Genelux
Investor Presentation
February 2024
systemic administration demonstrated dose dependent benefit | Genelux
Genelux
Investor Presentation
December 2023
systemic administration demonstrated dose dependent benefit | Genelux
Immix Biopharma
Investor Presentation
November 2023
clinical data month in late stage sarcoma well tolerated oat immix | Immix Biopharma
Recursion Pharmaceuticals
Investor Day
January 2023
clinical well understood clinical safety with a drug like profile further confidence prior studies suggestive of potential therapeutic benefit | Recursion Pharmaceuticals
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights